Davis Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Davis Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$60	Buy	+4	New	+$70	﹤0.01%	1174

Other funds holding TNDM

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

MMA

Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

FISPB

Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Davis Capital Management's TNDM Position: Q2 2026 in Review

Davis Capital Management opened a new position in Tandem Diabetes Care (TNDM) in Q2 2026: 4 shares worth $60. The stake represents ﹤0.01% of the portfolio and ranks #1174 among its holdings.

45 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

Davis Capital Management held 4 shares of Tandem Diabetes Care worth $60 as of Q2 2026.
Tandem Diabetes Care was a new Davis Capital Management position in Q2 2026.
Tandem Diabetes Care made up ﹤0.01% of Davis Capital Management's portfolio in Q2 2026, its #1174 holding.
45 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.